University of Michigan Law School

University of Michigan Law School Scholarship Repository
Book Chapters

Faculty Scholarship

2020

'Of Sound Mind and Body': A Call for Universal Drug Screening for
All Newborns
Frank Vandervort

University of Michigan Law School, vort@umich.edu

Vincent J. Palusci

NYU Grossman School of Medicine

Available at: https://repository.law.umich.edu/book_chapters/167

Follow this and additional works at: https://repository.law.umich.edu/book_chapters
Part of the Family Law Commons

Publication Information & Recommended Citation
Vandervort, Frank E. and Vincent J. Palusci. "'Of Sound Mind and Body': A Call for Universal Drug
Screening for All Newborns." In The Oxford Handbook of Children and Law, edited by James G. Dwyer.
Oxford Handbooks Online. Oxford: Oxford University Press, 2020.

This Book Chapter is brought to you for free and open access by the Faculty Scholarship at University of Michigan
Law School Scholarship Repository. It has been accepted for inclusion in Book Chapters by an authorized
administrator of University of Michigan Law School Scholarship Repository. For more information, please contact
mlaw.repository@umich.edu.

“Of Sound Mind and Body”: A call for universal drug screening for all new
borns

“Of Sound Mind and Body”: A call for universal drug
screening for all newborns
Frank E. Vandervort and Vincent J. Palusci
The Oxford Handbook of Children and the Law
Edited by James G. Dwyer
Print Publication Date: Apr 2020 Subject: Law, Family Law
Online Publication Date: Jun 2019 DOI: 10.1093/oxfordhb/9780190694395.013.4

Abstract and Keywords
Substance abuse is a major medical and social problem. Estimates suggest that each year
some 15 percent of the 4 million babies born in the United States are exposed to drugs or
alcohol. Research demonstrates that exposure to these substances is harmful to the chil
dren in both the short term and across their developmental trajectory. This chapter sum
marizes the harms that might result from such prenatal exposure and considers the ways
that both federal and state law respond to this. The chapter argues for universal drug
testing of newborns in an effort to ascertain whether they have been prenatally exposed
to such substances so that treatment and other services can be provided.
Keywords: drugs, newborn, substance abuse, tobacco, alcohol, children’s rights, health care, child protection,
screening, CAPTA

SUBSTANCE abuse is a major health and social problem in the United States. The Nation
al Institute on Drug Abuse (NIDA) estimates that in 2013, 24.6 million Americans used an
illicit drug within the month of being surveyed, amounting to 9.4 percent of the popula
tion; more than 17 million Americans abused alcohol; more than 4 million met diagnostic
criteria for dependence on marijuana; 1.9 million were dependent on or abused prescrip
tion pain relievers; some 855,000 used cocaine; and more than 22.5 million Americans
were in need of substance abuse treatment. Many are women of childbearing age, and
pregnant women engage in a substantial portion of this substance abuse. Survey evi
dence suggests that 15.8 million women used illicit substances (e.g., cocaine or heroin) or
used licit substances illicitly (i.e., used prescription medication without a prescription) in
2014, which equated to 12.9 percent of women over 18 years of age.1 A woman’s risk for
substance abuse is highest during the same years that she is most likely to become preg
nant.2 Substance use by childbearing age women is rising. From 2002 to 2014, for exam
ple, the prevalence of self-reported, past-month marijuana use among US adult pregnant
women increased from 2.4 percent to 3.9 percent, while 14.6 percent of pregnant adoles
cents in the United States aged 13 to 18 reported past-month marijuana use.3
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Each year in the United States, approximately four million babies are born.4 The National
Center on Substance Abuse and Child Welfare estimates that 15 percent of those children
are born having been exposed to alcohol or illicit drugs.5 Drug exposure (p. 66) during
pregnancy poses a number of immediate and long-term dangers to the physical and emo
tional well-being of an infant and child, and the effects vary from prenatal death to life
time neurodevelopmental delays. These are moderated by the type of drug, the timing
and frequency of exposure during gestation, other substances present, maternal health,
and factors in the infant. One serious immediate effect, neonatal abstinence syndrome, in
creased substantially in the early years of the twenty-first century. In 2012, the syndrome
was diagnosed in 21,732 infants in the United States, representing an increase by a fac
tor of five since the year 2000.6 This is an underestimate because there is no foolproof
method to determine with certainty whether a pregnant woman has used drugs or alco
hol, and infants are not reliably identified in the neonatal period.7
The most inclusive means of identifying prenatally exposed newborns is to test their
meconium (the first feces of a newborn), but this captures only drugs used during the lat
ter stages of pregnancy. Toxicology tests of newborns’ urine are less accurate, capturing
only more recent infant exposure to maternal drug use. Some have begun testing umbili
cal cords, but this practice is not universal. Many health care professionals rely on the
identification of potential risk factors during the prenatal or perinatal periods which have
been associated with maternal drug use before they order drug testing on a newborn
child. Risk factors that trigger testing might include inadequate prenatal care, delivery
outside the hospital, a history of drug use, removal of other children by child protective
services (CPS), or the identification of intrauterine findings such as unexplained neonatal
stroke or growth retardation. Medical history-taking, which plays a critical role in this as
sessment, is problematic; there is considerable evidence that pregnant women underre
port their use of alcohol and illicit drugs because they fear the consequences that might
flow from that use, such as social ostracism, involvement of CPS and, in some jurisdic
tions, criminal prosecution.8 For example, a study involving more than 8,500 mother-new
born dyads found that more than one-third of the drug-using pregnant women failed to
self-disclose their drug use—even when a structured interviewing protocol was used—
which was only later discovered with meconium analysis.9 Another study in a community
hospital found that clinical indicators identified less than one-fourth of exposed babies
when compared to meconium test results.10 Thus, most newborns are currently not identi
fied by history or testing to determine whether they were prenatally exposed. Even when
testing occurs, the results are imperfect at identifying all substance use during pregnan
cy.
Public authorities have long been concerned about substance abuse. Prenatal exposure to
alcohol has been of concern to medical professionals since at least the early 1830s.11
Concern about particular substances comes in waves as the public’s taste for a particular
drug waxes and wanes, with alcohol and tobacco being more constant. Concern by public
authorities is often racially tinged, and there are racial and socioeconomic disparities in
substance abuse reporting and treatment. For example, in the 1890s concern was focused
on the use of opium by Chinese immigrants. In the 1930s there was concern about “reefer
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madness,” which was focused on the Latino (p. 67) community. In the 1980s, use of co
caine captured the public’s attention. Although there was increased use of both the pow
dered form of the drug and the cheap, smokable form known as “crack,” public authori
ties’ concern was focused more on crack, which was predominantly used by impoverished
African Americans, than on the powdered form preferred by the middle classes and
whites. Methamphetamine use, primarily by rural whites, rose sharply in the late 1990s
and early 2000s.12 Later in the 2000s, prescription opioid abuse rose to concerning lev
els. When officials began to crack down on opioid prescription mills, heroin usage in
creased, and methamphetamine use has also recently resurged.13 As this chapter is being
written, opioid use (including prescription opioids, heroin, and synthetic forms such as
fentanyl) is at epidemic levels. As this summary makes plain, concern about prenatal ex
posure to drugs and alcohol is not a recent phenomenon. Over the past half-century we
have learned a great deal about how prenatal substance use and abuse impacts inchoate
children and about its increased risks for later child abuse and neglect.
Yet the law provides few options to protect children from the harmful impact of prenatal
substance exposure. With few exceptions, state criminal law does not provide a mecha
nism for compelling a substance-abusing pregnant woman into treatment, because most
courts have interpreted various provisions of their criminal statutes (e.g., murder,
manslaughter, child abuse, child endangerment) to be inapplicable to the inchoate
child.14 And, of course, prosecution alone does little or nothing to prevent her use of
drugs, to treat her underlying addiction, or to address the needs of her unborn baby.
Though incarceration might interrupt a woman’s substance use, both incarceration itself
and, in the case of an addicted pregnant woman, withdrawal from that substance induce
stress that presents its own set of harms to the developing child.
A few states have enacted statutes authorizing courts to civilly commit a pregnant woman
for the purpose of receiving drug treatment.15 These statutes are infrequently used, how
ever, and they present a host of challenges such as inadequate treatment facilities to care
for the women who are committed and a lack of financial resources to pay for needed
treatment. Additionally, there are active constitutional challenges to these statues, and it
is unclear whether they will pass constitutional muster.16 As a result, children will contin
ue to be born having been prenatally exposed and to suffer a variety of harms due to ma
ternal use of illicit drugs and alcohol.

1. Impact of Prenatal Drug Exposure on Chil
dren
Prenatal exposure to drugs of abuse often has deleterious effects upon inchoate children
that include “long-lasting changes to brain structure and function.”17 The precise impact
on an individual child will vary depending on the substance used, the frequency of use,
the amount used, and when during the pregnancy it was used. A crucial factor is whether
the pregnant woman engaged in polysubstance abuse (p. 68) while pregnant, which is typ
ical (e.g., use of alcohol and marijuana, heroin and cocaine, or cocaine and alcohol). Addi
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tionally, a host of environmental factors such as timing and amount of prenatal medical
care, quality of nutrition, and the presence of other life stressors in the pregnant
woman’s environment (e.g., poverty or domestic violence) may influence how the develop
ing child is impacted by the substance use.
Medical and social science researchers have identified a number of short- and long-term
harmful impacts of prenatal exposure to illicit drugs and alcohol. The specific impacts on
individual children vary, ranging from intrauterine death and increased risk for sudden in
fant death syndrome to long-term neurodevelopmental disabilities.18 Post-birth environ
mental factors play an important role in how a particular child is impacted by prenatal ex
posure. For example, children with prenatal alcohol exposure and subsequent trauma
fare worse neurodevelopmentally than children who have experienced only post-birth
trauma.19 What follows is a brief summary of the research as it relates to each identified
substance.20

1.1. Tobacco
Cigarette smoke and nicotine are the most commonly used substances during pregnancy.
Estimates suggest that some 18 percent of pregnant women smoke cigarettes. Smoking
deprives the inchoate child of vital nutrients and oxygen while exposing him or her to
harmful compounds. The carbon monoxide and nicotine in cigarettes impede the supply
of oxygen to the developing child. The chemicals in cigarettes—lead, arsenic, and similar
substances—may have a more harmful impact on the inchoate child than on the mother.
After crossing the placenta, nicotine accumulates in the child such that the child will have
higher concentrations of the drug than the mother. Smoking has been definitely linked to
infant low birth weight, premature delivery, and birth defects, as well as a variety of postbirth medical and emotional problems, decreased pulmonary function, sudden infant
death syndrome, and behavioral problems such as attention deficit hyperactivity
disorder.21 Children exposed to tobacco smoke prenatally are more likely to smoke them
selves even after controlling for later maternal smoking.22

1.2. Alcohol
Between 10 percent and 15 percent of pregnant women report using alcohol while preg
nant, with 3.9 percent reporting binge drinking and 0.7 percent reporting heavy alcohol
use.23 Estimates suggest that 1 percent of children suffer deleterious impacts as a result
of prenatal exposure to alcohol, approximately 400,000 children each year.24 The impacts
of prenatal exposure to alcohol have been studied for decades and so are more well
known and well documented than those from other drugs of abuse. Fetal death is the
most extreme outcome from drinking alcohol during pregnancy. In 1973, “fetal alcohol
syndrome” entered the medical lexicon and has since been refined to fetal (p. 69) alcohol
spectrum disorder (FASD), reflecting gradations in the impact of prenatal exposure on
the developing child. Different terms are used to describe FASD depending on the type of
symptoms.25 Fetal alcohol syndrome (FAS) represents the most involved end of the FASD
spectrum, with anatomic and neurologic effects. Many people with FAS have abnormal fa
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cial features, growth problems, and central nervous system (CNS) problems. FAS can
cause problems with learning, memory, attention span, communication, vision, or hear
ing. People with FAS might have a mix of these problems. Many have a hard time in
school and trouble getting along with others. People with alcohol-related neurodevelop
mental disorder (ARND) have intellectual disabilities and problems with behavior and
learning. They tend to do poorly in school and to have difficulties with math, memory, at
tention, judgment, and poor impulse control.
People with alcohol-related birth defects (ARBD) typically have problems with the heart,
kidneys, or bones or with hearing. Prenatal exposure to alcohol is a leading cause of men
tal retardation in North America.26 Prenatal exposure to alcohol has been associated with
impairments as wide-ranging as attention deficit disorder, difficulties with memory, ver
bal fluency, and executive functioning of the prefrontal cortex, among other deficits.27
Children exposed to alcohol in utero are at heightened risk for mood disorders and psy
chopathology.28 Psychologist Dr. Tina Birk Irner summarizes the impact of prenatal alco
hol exposure as resulting in “cognitive and behavioral deficits that impair both the social
and occupational future of the person exposed with a need in severe cases for lifelong as
sistance in order for that person to function at an optimal level.”29 Among children in the
foster care system, there is evidence that the incidence of FASD has been either underes
timated or the diagnosis has simply been missed, yet it is identified in a disproportionate
number of children in care.30

1.3. Marijuana
Marijuana has long been among the most commonly used illicit drugs by pregnant
women.31 Approximately 5 percent of pregnant women report using marijuana during the
first trimester of pregnancy, with 2.9 percent reporting second trimester usage and 1.4
percent use during the third trimester.32 In recent years, there has been movement to le
galize marijuana for either medical or recreational purposes, and usage has increased
significantly.33 Marijuana has historically been considered an illicit drug and remains a
Schedule I substance under federal law. The movement to legalize it may portend in
creased use by pregnant women, which is problematic, in part because of higher concen
trations of THC (tetrahydrocannabinol), the active ingredient in marijuana, in recent
years.34 Regardless of its legal status, when used during pregnancy, marijuana has been
linked to a number of negative impacts on child development. First, these children experi
ence sleep disturbances at higher rates through the first three years of life. They also
manifest lower than normal verbal and memory acuity, increased impulsivity, decreased
attention, hyperactivity, and impaired cognitive development (lower IQ scores) and execu
tive functioning. By age six, children exposed to (p. 70) marijuana in utero show increased
attention deficits, impulsivity, and hyperactivity.35 Exposure to marijuana in utero has
been linked to increased problems with attention, learning, and memory and to juvenile
delinquency by age ten. At age fourteen, even when controlling for maternal substance
use, household income, home environment, maternal IQ, and race, youth exposed to mari
juana in utero had significantly higher levels of juvenile delinquency. Heavy use of mari
juana during pregnancy nearly doubles the possibility that a child will be delinquent by
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age fourteen.36 After reviewing the research regarding marijuana’s impact on the in
choate child, Ross and her colleagues concluded that the “data indicate that prenatal
marijuana exposure has significant effects on multiple neurobehavioral outcomes—
deficits that are enduring, particularly at the level of executive function [i.e., the cogni
tive and intellectual function of the brain that enhances one’s ability to exercise judgment
and to control impulses].”37

1.4. Cocaine
Cocaine use during pregnancy has been linked to numerous prenatal complications as
well as long-term developmental problems post-birth. Use in the early stages of pregnan
cy is associated with reduced gestational age, lower weight at birth, and smaller head cir
cumference even when other possible causes are controlled for.38 Children whose moth
ers used cocaine during pregnancy experience “generalized growth retardation.”39 In
terms of behavior, Ross et al. summarize the impact on newborns prenatally exposed to
cocaine as experiencing “abnormalities related to lower arousal, poorer quality of move
ment and self-regulation, higher excitability, jitteriness, and more non-optimal reflexes,”
circumstances that persisted, and in some cases worsened, after one year.40 These chil
dren experience growth deficiencies, which in some children have been found to persist
until at least the age of ten. While cocaine itself “does not appear to lower global intelli
gence, there is consistent evidence of poor cognitive performance in language skills, be
havior, and executive functioning.”41 A secure emotional attachment to a primary caregiv
er is crucial to healthy child development. Children exposed to cocaine in utero, however,
may demonstrate increased incidence of insecure attachment to a primary caregiver.42
Cocaine exposure has been correlated with increased aggression and juvenile delinquen
cy by age nine. More recent research utilizing structural and functional magnetic reso
nance imaging (MRI) have identified long-term, structural abnormalities to the cortical
and limbic regions of the brains of children prenatally exposed to cocaine.

1.5. Methamphetamine
While the prevalence of use of methamphetamine (meth) is uncertain, our best informa
tion is that about 5 percent of women report using meth during pregnancy.43 In the Unit
ed States, the early 2000s saw a dramatic upswing in the use of meth, which (p. 71)
seems to have been reduced in the following decade as prescription opioid misuse in
creased substantially. By 2017, meth use was again on the rise. Although meth is a com
monly abused drug, less is known about its long-term impact on child development.44
What is known is that continuous meth use during pregnancy is associated with prema
ture birth and low birthweight.45 It is also associated with growth restrictions, shorter
length at birth and smaller head circumference. Some meth-exposed newborns display
cardiac and cranial anomalies similar to those experienced by neonates who experienced
asphyxiation during pregnancy.46 Meth exposure in utero appears to have a number of
harmful effects on a child’s brain development, including development of visual-motor in
tegration, verbal and spatial memory, and attention. Specific regions of meth-exposed
children’s brains are smaller than those of non-exposed but otherwise comparable chil
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dren.47 Critically, the research suggests that discontinuing meth use at any point during
pregnancy has a positive impact on the resultant child, so intervention with pregnant
meth users is crucial.48

1.6. Opioids
Estimates suggest that the number of children born experiencing neonatal abstinence
syndrome as a result of prenatal opioid exposure in the United States tripled between
2000 and 2009.49 The number of children born prenatally exposed to opioids has strained
the nation’s health care systems and overwhelmed children’s protective services agencies
around the country.50 Opioids are a class of drugs that include the illegal drug heroin,
synthetic opioids such as fentanyl, and pain relievers available legally by prescription,
such as oxycodone, hydrocodone, codeine, morphine, and many others. Use of opioids
during pregnancy has a number of negative impacts on the inchoate child. During the
pregnancy, these might include premature labor, preeclampsia (increased maternal blood
pressure), placental insufficiency, intrauterine growth deficits, or death. In addition to ex
periencing withdrawal, many children born to mothers who use opioids have low birth
weights and smaller head circumference than non-exposed children. Children exposed in
utero to opioids have “smaller for age intracranial and brain volumes” and other physical
deformities.51 Opioid-exposed children show increased rates of motor and cognitive im
pairments, hyperactivity, and inattention.52 In summarizing the research regarding the
impact of in utero heroin exposure, Irner explained that children born opioid-dependent
scored higher on tests of attention deficits (regardless of whether the children were
raised in their biological homes or in adoptive homes); those born exposed and raised at
home scored worse than those who were exposed and adopted or a comparison group of
children who grew up in low socioeconomic status households.53 Children exposed to opi
oids demonstrated an increased incidence of insecure attachment.54 Recent research uti
lizing MRI and functional MRI technology has begun to isolate specific locations in the
brains of newborns that are impacted by the use of various substances. “Structural brain
deficits have been observed in children exposed to opioids prenatally,” according (p. 72)
to Irner.55 Ross and her colleagues concluded, “The damage of prenatal opiate exposure
is debilitating and long lasting.”56
Maternal opioid addiction might be treated with other opioid-based medications (e.g.,
methadone, buprenorphine). When used under close medical supervision, these prescrip
tion opioids are less harmful than the illicit drugs of choice (e.g., heroin). However, “they
are not without substantial risk, as they can cross the placenta and alter development.”57
There have also been differences noted in which drug is used based on racial and socioe
conomic factors. Use of these prescription opioids may result in the same complications
as illicit opioid use: premature birth, decreased birthweight, smaller head circumference,
respiratory difficulties, and other complications at birth. After birth, a number of children
whose mothers are treated with these drugs experience neonatal abstinence syndrome, a
withdrawal syndrome, although it appears that cognitive deficits may not be as prevalent
as with illicit opioid use.
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In a review of the literature on the impact of various substances on child development,
Dr. Tina Birk Irner concluded that “the evidence is convincing on consequences of prena
tal alcohol, but also of other substance exposure and developmental consequences into
adolescence…. [C]hildren born to substance-using women have been shown to be vulner
able across cognitive, emotional and social function into adolescence.”58 Irner’s summa
tion reflects the medical consensus that children born to substance-abusing mothers suf
fer both short- and long-term effects that in any other context would, without hesitation,
be considered child maltreatment. In addition to the drugs listed here, there are a num
ber of other illicit substances such as phencyclidine and “designer” drugs and high-poten
cy THC that may have other even more dangerous effects, but these are less well studied
and long-term outcomes are not yet available.

2. Children’s Rights in the Health Care Context
Historically, the civil law viewed a child’s legal interests as synonymous with those of his
or her parents. Thus a child could not bring suit against a parent for damages caused by
parental behavior or decision-making.59 Since 1963, however, courts have steadily eroded
the intrafamilial tort immunity doctrine, allowing children to sue their parents for injuri
ous conduct.60 It was through tort law that a child’s right to be born healthy entered
American legal doctrine, entitling him or her to a remedy if some negligent actor violated
that right.61 “[J]ustice requires,” the New Jersey Supreme Court wrote in 1960, “that the
principal be recognized that a child has a legal right to begin life with a sound mind and
body.”62 The right to be born of sound mind and body was eventually applied to harm to a
child by his or her mother during pregnancy. Courts today permit children to bring suit
against their mothers if they are harmed by the mother’s behavior during pregnancy.
Courts have extended this principle to a pregnant (p. 73) woman’s negligent use of pre
scription medications, even where those drugs were recommended by and administered
under the supervision of her treating physician.63
In Parham v. J. R., the U.S. Supreme Court addressed the rights of a minor child to an ad
versarial hearing before being committed to a mental health facility by his or her parents.
While holding that no adversarial hearing was required pre-admission, the majority of the
justices acknowledged that a child has the right to be free from unnecessary bodily re
straint that accompanies psychiatric hospitalization. The Court made clear its view that
parents generally are charged with both the right and the “high duty” to make medical
decisions on behalf of their children free of interference by the state.64 “The law’s con
cept of the family rests,” Chief Justice Burger wrote for the Court’s majority, “on a pre
sumption that parents possess what a child lacks in maturity, experience, and capacity for
judgment required for making life’s difficult decisions…[and] that natural bonds of affec
tion lead parents to act in the best interests of their children.”65 The majority, however,
recognized that in some instances parents will not act with their children’s best interests
at heart: “[T]he incidence of child neglect and abuse cases attests to this.”66
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When the child’s interests might diverge from those of the parents, the Parham Court ac
knowledged, children are entitled to some process before being committed to a psychi
atric facility. The process due the child was embodied in an independent medical judg
ment by a qualified member of the hospital’s medical staff. This demonstrates that health
care professionals owe an independent duty of care to the child-patient that is separate
from any duty owed to the child’s parents. In Grodin v. Grodin,67 this separate duty pro
vided a basis on which a child, who was harmed by the physician’s allegedly negligent ad
ministration of medication during the prenatal period, could bring suit.68 The physician’s
separate duty to the child-patient is implicated when a pregnant woman uses drugs or al
cohol. Thus, for example, the Court of Appeal of California has held that because of the
conflict of interest present in such a case, a parent cannot assert a child’s physician-pa
tient privilege in order to exclude from evidence in a child protection proceeding the
child’s medical records regarding the child’s prenatal exposure to illicit drugs and post
natal medical condition.69 However, such protections for sharing maternal information in
child protection cases is not uniform across the United States.
This principle—that a child has a right to be born of sound mind and body—has migrated
into the child protection context, which provides the state the opportunity to effectuate
its parens patriae interest in the welfare of the child.70

3. Child Protection and the Right to Be Born of
Sound Mind and Body
A 2003 federal law, the Keeping Children and Families Safe Act of 2003, required states
to mandate that birthing facilities report to child protection services a positive (p. 74) toxi
cology test result in any newborn, and to have a “plan of safety” for addressing the new
born child’s predicament of having a substance-using mother. But roughly half the states
ignored the mandate. Before enactment of the Comprehensive Addiction and Recovery
Act in 2016, only twenty states (corresponding to 31 percent of U.S. births) had laws re
quiring health care providers to report perinatal substance use to child protective author
ities, and four states (18 percent of births) had laws requiring reporting only when a
health care provider believed the substance use was associated with some other act of
child maltreatment. About one-half of states with any reporting law (thirteen states) have
had a provision promoting substance use disorder treatment in the perinatal period, typi
cally by requiring CPS to refrain from any coercive response to prenatal drug exposure if
the mother received or even simply made some effort to receive treatment.71 The 2016
act aimed to improve compliance and establish more detailed elements of a plan of safety.
Most courts in the United States that have considered the issue have concluded that state
child protection authorities may not assert authority over an unborn child, despite Roe v.
Wade’s (1973) recognition that the state has a compelling interest in the well-being of a
child late in pregnancy.72 Once a child is born, however, the state’s authority is universal
ly acknowledged. In numerous cases, courts have addressed the newborn’s rights when
he or she is born having been prenatally exposed to alcohol or drugs of abuse (for exam
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ple, New Jersey Division of Child Protection and Permanency v. Y.N. (2013); In the Inter
ests of H. (2003); In re Baby Boy Blackshear (2000); In re Ruiz (1986); In re Baby X
(1980)).73 A number of courts have held that the mere use of alcohol or illicit drugs by a
pregnant woman is insufficient to provide child protective authorities a basis to act to
protect a newborn. Rather, they have required the showing of a demonstrable, harmful
impact upon the child, such as experiencing withdrawal.74 Even when a harmful impact is
demonstrable, some courts have held that exposure to a legally prescribed narcotic, such
as methadone, taken as a result of maternal addiction and as part of a medically super
vised rehabilitation program, is an insufficient basis for a child protection court to assert
authority over a newborn. Thus, in New Jersey Division of Child Protection and Permanen
cy v. Y.N., that state’s Supreme Court ruled that although the newborn at issue had been
born physiologically dependent on methadone and experienced withdrawal symptoms,
the mother’s use of the methadone as part of a bona fide treatment program for her hero
in addiction was not alone a reason for the child protection court to find that the child
had been maltreated.75 A number of other courts, however, have held that a child has a
right to be born of sound mind and body.76 When demonstrable harm to the child is
shown, that is, the child is not born “of sound mind and body,” these courts have ruled
that prenatal exposure alone is a sufficient basis for child protection courts to act to re
move children from their parents’ home and place them into the protective custody of the
state.77 Still other courts, while not employing this specific formulation of the right, have
held that a woman’s substance use while pregnant alone provides a sufficient basis for
child protection authorities to act to secure the newborn’s safety. Even where prenatal
substance abuse might provide a basis for protective intervention, standing (p. 75) alone
it might be an insufficient rationale to support permanent termination of parental
rights.78
However framed, newborns lack agency to be able to act to protect their own interest.
John E. B. Myers, a law professor and advocate for abused and neglected children, has
noted that “[a]n interest stripped of a method of enforcement is a feckless thing.”79 For
the state to act on behalf of children, legal authorization needs to be clear and child wel
fare agencies need to learn about newborns for whom parental substance abuse has cre
ated special needs and put them at further risk if they go home with the parent.

4. The State’s Interest
While universal screening should be considered a right of the newborn child, it also
serves to protect important state interests. The state possesses a “substantial interest” in
the possibility of life represented by a developing child “throughout pregnancy.”80 At the
point of viability, the state’s interest evolves from “substantial” to “compelling.”81 Once
the child is born, the state’s compelling interest in the child’s safety and well-being has
been described as “urgent.”82 Somewhat similarly, the state has a legitimate interest in
identifying and providing services for its adult citizens needing mental health and sub
stance abuse treatment, and in ensuring community safety.83
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When the state provides health care, the Parham Court noted, the “State obviously has a
significant interest” also in the conservation and wise use of its financial resources.84
Nearly half of each year’s births are publicly financed by Medicaid.85 Those births that
are privately financed are also of significant interest to the state because the increased
long-term costs associated with giving birth to a child prenatally exposed to these sub
stances drives up health care costs. Earlier identification would allow for earlier treat
ment of symptoms to prevent progression and long-term harm. It also would reduce longterm costs by providing medical and developmental services to optimize child develop
ment, educational achievement, and productivity as adults.
Given the impact of prenatal exposure, the state’s interest in the conservation and wise
use of its resources extends far beyond the immediate postnatal period. Indeed, it is now
clear that children born prenatally drug-exposed disproportionately utilize publicly fund
ed services—e.g., mental health, social, specialized educational—across much of their
lifespan.
The U.S. Congress has mandated that, as a contingency to the states’ receipt of funds
pursuant to the Child Abuse Prevention and Treatment Act (CAPTA), each state must have
in place a mandatory reporting procedure that requires medical personnel to report when
a newborn is “affected by substance abuse or withdrawal symptoms from prenatal drug
exposure, or fetal alcohol spectrum disorder.”86 While the federal law does not explicitly
define prenatal exposure in and of itself as child maltreatment, its mandate that these
children be reported to children’s protective services is a frank recognition of the par
ents’ harmful behavior toward their children. By including this (p. 76) provision in CAPTA,
Congress has made clear that an independent judgment by child protective authorities is
necessary to assure the protection of the state’s interest and at least a minimal level of
parental care for these exposed children. Thus, just as the Supreme Court concluded in
Parham’s context of civil commitment that parents were not entitled to “absolute and un
reviewable discretion,” it is entirely rational in order to protect the child’s interests and
the interests of the state that parents not have unlimited discretion in the context of test
ing at birth for in utero exposure.87
Despite enactment in 2016 of the Comprehensive Addiction Recovery Act, fortifying
CAPTA’s mandate to address the needs of substance-exposed newborns, as of 2018, only
twenty-three states and the District of Columbia mandated that CPS be notified by health
care providers who suspect prenatal substance exposure.88
Furthermore, targeted testing of individual mother-child dyads fails to identify many ex
posed children. Targeted testing has been criticized as disproportionately targeting poor
and minority-race women, leaving white newborns less protected. Because of this limita
tion, a more robust response is essential to protect the child’s right to be born of sound
mind and body and to effectuate the state’s interest in the child’s health and well-being. A
program of universal testing would be an effective method of protecting both the child’s
right and the state’s interest. Prompt identification is associated with improved outcomes
for the child and holds the potential for reducing health care costs in the short term and
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associated public spending in the longer term. As the government has become more in
volved in private health care markets with the enactment of the Affordable Care Act, its
interest in identifying those children prenatally exposed to drugs and alcohol who are
served by private insurance has likewise increased. An important step toward protecting
the rights of children and the interests of the state is through mandated universal screen
ing of neonates for prenatal exposure to alcohol and drugs of abuse.

5. Universal Screening of Newborns
Lester et al. have observed, “The prevalence of prenatal drug exposure is very difficult to
estimate because of flaws in all methods of identification.”89 As noted earlier, research
suggests that women often mislead their healthcare providers about their substance use
and abuse when pregnant. That may be, in part, because they fear the non-medical conse
quences attendant to disclosure, referrals to CPS, or criminal prosecution. For example,
in one large study of 11,800 mother-child dyads at four different hospitals around the
country, researchers analyzed the meconium of 8,527 children. They found that 10.7 per
cent of the children tested positive for cocaine and/or opioids. In 38 percent of the cases
in which the meconium was positive for cocaine or an opioid, the mother denied use.90 In
another study, 43 percent of the women tested positive for illegal drugs during their preg
nancies while only 11 percent admitted drug use. Urine drug screening of mothers and
babies is problematic because most substances break down and leave the body relatively
quickly (for example, cocaine metabolites can be (p. 77) identified for only 96 to 120 hours
after ingestion). Meconium testing, which is the most inclusive method for testing new
borns, only captures drug use in the second half of pregnancy.91
Clearly, self-reporting and targeted testing are ineffectual in identifying children exposed
in utero to these toxins. A more certain means of identifying exposed children is neces
sary if a violation of their right to be born of sound mind and body is to be remedied. Postbirth screening of infants for prenatal exposure to substances must become universal.
States currently mandate a number of procedures and tests for newborns based on public
health and other laws. States should amend their public health statutes to require that
newborns be tested for the presence of alcohol, tobacco, and other drugs of abuse. To in
centivize states to do so, Congress should amend CAPTA to require that each state imple
ment universal drug screening of newborns as part of its state plan.
The use of universal screening as a means of identifying substance-exposed newborns has
been discussed for some time among medical care providers. The American College of
Obstetricians and Gynecologists (ACOG) recommends that “[b]efore pregnancy and in
early pregnancy, all women should be asked about their use of tobacco, alcohol, and other
drugs, including marijuana.”.92 Rather than biologic testing of mothers and newborns, the
ACOG has recommended use of structured interviews, although even these are known to
under-identify drug-using pregnant women.93 It is clear, however, that in making these
recommendations, the ACOG views the pregnant woman and not the newborn as the pri
mary, if not the exclusive, recipient of the physician’s professional care and attention.
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Beyond the ACOG, the American Academy of Pediatrics (AAP) has recommended that this
universal questioning of pregnant women about substance use should occur at routine
health care visits and at several points throughout prenatal care and be applied equally to
all women, regardless of age, race, ethnicity, or socioeconomic status. That recommenda
tion should be supported,94 but it does not go far enough.95
Medical commentators have from time to time discussed the possibility of conducting uni
versal screening of newborns for prenatal exposure,96 and they have advanced two ratio
nales for universal testing: 1) it would eliminate the race and class bias that seems to be
inherent in targeted testing regimes; and 2) since early identification is critical to provid
ing effective treatment, universal testing would ensure that exposed children receive the
array of services they may need as quickly as possible.97 In 2016, the U.S. Department of
Health and Human Services, Administration on Children, Youth and Families (ACF) issued
policy guidance regarding the implementation of the Comprehensive Addiction and Re
covery Act in which it implied that universal testing was best practice. Unfortunately, the
ACF neither required nor incentivized states to provide universal testing for newborns.
Despite its identified benefits, commentators and those in positions of authority have ex
pressed reluctance regarding universal testing of neonates.98 While there may be other
concerns (cost, chain of evidence of specimens, false positives, and false identification of
drugs administered by medical professionals), the primary reservations focus (p. 78) on
the potential legal and social impacts to the mother when she delivers an exposed child.
For instance, Barry M. Lester and colleagues have written:
[U]niversal testing of infants places hospitals in a precarious position.…[I]f a new
born exhibits a positive toxicology screen and the state has a mandatory reporting
law, the hospital has a responsibility to report that fact to the necessary authori
ties in order to ensure the protection of the welfare of the child. In cases such as
this there is a conflict between the hospital’s responsibility to protect the confi
dentiality of the mother and the responsibility to protect the welfare of the
infant.99
This perspective is deeply flawed for several reasons. First, it fails to acknowledge that
the child is a separate patient from the mother, a patient to whom the medical profession
als and hospitals owe a separate legal duty. This separate duty is what forms the founda
tion of a child’s separate cause of action in tort against a physician for prenatal injuries.
Second, that a physician would intentionally fail to understand the medical condition of
one patient because of some possible non-medical implication to another person would
seem to be an egregious violation of that physician’s responsibilities—both legal and as a
matter of professional medical ethics—to that infant-patient. Finally, the general duty of
confidentiality in this context is a legal duty, one that is overridden and vitiated in the
specific context of child maltreatment by the enactment of mandatory reporting
statutes.100 Moreover, confidentiality between a doctor and her patient is a statutory cre
ation in derogation of the common law. The rationale for confidentiality laws is that they
encourage patients to fully disclose information to their physician in order to obtain can
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did medical advice. But this rationale plainly does not apply in the context of substanceabusing pregnant women. Courts have held that these legislatively created rights of confi
dentiality and the evidentiary privilege that flows from them should be narrowly con
strued.101 Congress and state legislatures have explicitly eliminated the confidential rela
tionship between the physician and patient in the circumstance of a child being born ex
posed to illicit drugs or alcohol.
None of these commentators has addressed universal screening from the perspective of
the child’s legal right to be born of sound mind and body. Early identification of prenatal
exposure portends real and important benefits for newborn children and their families,
such as earlier identification of NAS, referral for specialized assessment and treatment of
developmental delays, providing services to address risks in the home associated with
drug use and abuse that place the infant at further risk, and the earlier identification of
mothers (and fathers) needing substance abuse treatment. Identifying these children ear
ly maximizes the possibility of a positive medical outcome and decreases the chances of
medical complications. As with many medical conditions, early identification of prenatal
exposure is key to improving both short- and long-term outcomes for the child-patient.102
Early identification also enhances the patient’s treatment options and enhances patient
self-determination.
Patient self-determination is fundamental to the ethical delivery of health care services to
patients, and it includes a duty to be honest with the patient about diagnosis (p. 79) and
prognosis.103 While this duty to the neonate-patient is typically met through the parent,
when there is a conflict between the interests of the parent and the child in the context of
child maltreatment, as Parham made clear, the medical provider’s duty is squarely with
the child-patient. That duty is further reinforced by state child protection laws that pro
vide for civil and criminal penalties when mandated reporters fail to notify child protec
tion authorities when they reasonably suspect maltreatment. These young children’s lack
of agency, their utter helplessness, would also seem to militate strongly in favor of a rule
that medical providers have the highest duty to ensure that their condition be identified
and treated.
Despite the lack of legal mandate, hospitals could adopt a policy of universal testing. Yet
few do because of costs and fear of liability under the current legal framework. A 2017
survey of Iowa birthing hospitals found that no hospital in the state conducts universal
testing of newborns.104 A survey of Maryland birthing hospitals found that only two of
thirty-one hospitals conducted universal screening of newborns for prenatal exposure.105
Thus, all drug-affected newborns are not identified and reported.
In response to the present opioid epidemic, seven hospitals in the Cincinnati area began
in 2013 a program of testing all pregnant women and their newborns. A study of 2,995
pregnant women at one of the hospitals found that 159 (5.4 percent) of the women tested
positive for drugs, with 96 of those women testing positive for opioids. Of the women who
tested positive for opioids, 19 (20 percent) lacked any identified risk factors and so would
likely have been missed by any targeted testing protocol, and 33 percent of infants ex
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posed to drugs other than opioids would not have been identified absent the policy of uni
versal testing.106 This program illustrates the utility of universal testing in identifying
more children prenatally exposed, thereby providing a mechanism to remedy violations of
their right to be born of sound mind and body and an opportunity to intervene earlier
with treatment and services for the infant and family.
For all the reasons outlined in this chapter, CAPTA should be amended to require univer
sal screening of newborns. Consistent with that mandate, states should enact laws requir
ing universal screening. Children testing positive should be reported to CPS as is consis
tent with state reporting laws.

6. Conclusion
Each year in the United States, large numbers of children are born exposed to drugs and
other dangerous substances. This exposure is harmful to children and violates their right
to be born “of sound mind and body.” It also puts undue strain on public systems, which
disproportionately bear the financial burden for the medical, child protective, education,
and mental health services these children and families will need, sometimes across their
entire lifespan. Universal newborn drug testing should (p. 80) be implemented in order to
protect the rights of the child and the interests of the state. To do this, the states should
amend their laws regarding child birth to mandate such testing, and the federal govern
ment should amend CAPTA to provide states an incentive to do so.
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